RecruitingNCT05356039

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer - a Multicenter Prospective Observational Study


Sponsor

Umeå University

Enrollment

300 participants

Start Date

Apr 19, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to assess overall survival, quality of life and resection rates in locally advanced pancreatic cancer


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is following and collecting data on people with locally advanced pancreatic cancer — tumors that have grown into nearby blood vessels or tissue but have not yet spread to distant organs — to understand which patients benefit most from surgery, chemotherapy, or other treatment combinations. **You may be eligible if...** - You have a confirmed or suspected invasive pancreatic cancer - Your tumor is classified as borderline resectable or locally advanced (meaning it may or may not be operable) according to standard oncology guidelines - You are 18 or older **You may NOT be eligible if...** - Your tumor is a pancreatic endocrine (hormone-producing) tumor rather than the common type - You have cancer arising near the pancreas but not within the pancreas itself (non-pancreatic periampullary tumor) - Your cancer has spread to distant organs (e.g., liver, lungs) - You are unable to understand or consent to participation due to language, mental, or cognitive barriers Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Surgical Clinic at Umeå University Hospital

Umeå, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05356039


Related Trials